Page last updated: 2024-08-26

mci 9038 and Cardiovascular Diseases

mci 9038 has been researched along with Cardiovascular Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elliott, WG; Gurbuz, AT; Zia, AA	1
Matthai, WH	1
Das, P; Hamdalla, H; Jozic, J; Moliterno, DJ; Mukherjee, D; Steinhubl, SR; Ziada, K	1
Fujita, T; Kumon, K; Naito, Y; Nakajima, N; Tanaka, K	1
Kario, K; Koide, M; Matsuo, T	1

Reviews

4 review(s) available for mci 9038 and Cardiovascular Diseases

Article	Year
Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005, Volume: 27, Issue:1 Topics: Ancrod; Antibodies; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Practice Guidelines as Topic; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Sulfonamides; Thrombin	2005
Treatment of heparin-induced thrombocytopenia in cardiovascular patients. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia	2006
Heparin-induced thrombocytopenia and cardiovascular diseases. American heart journal, 2006, Volume: 152, Issue:1 Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sensitivity and Specificity; Sulfonamides; Thrombocytopenia; Thrombosis	2006
Development of argatroban, a direct thrombin inhibitor, and its clinical application. Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:6 Topics: Anticoagulants; Antithrombins; Arginine; Cardiovascular Diseases; Drug Monitoring; Humans; Ischemic Attack, Transient; Molecular Weight; Pipecolic Acids; Sulfonamides	1997

Other Studies

1 other study(ies) available for mci 9038 and Cardiovascular Diseases

Article	Year
Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation. Critical care medicine, 1984, Volume: 12, Issue:12 Topics: Adult; Aged; Antithrombin III; Arginine; Cardiovascular Diseases; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Care; Sulfonamides	1984

Article

Year

Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.

Critical care medicine, 1984, Volume: 12, Issue:12

Topics: Adult; Aged; Antithrombin III; Arginine; Cardiovascular Diseases; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Care; Sulfonamides

1984